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AbstractMethods for the quantitative determination of loratadine tablets by differential spectrophotometry and photo-colorimetry 
have been developed. During the procedure parameters (range of application methods, stability, specificity, robasnist, convergence, internal laboratory accuracy (precision), accuracy, reproducibility) have been considered. The results indicate that the method photo-colorimetry has not met modern criteria for analytical methods for quantitative determination of parameters such as stability, accuracy and linearity, so other validation parameters (robasnist, convergence and inter-laboratory precision) have been determined only by spectrophotometric methods. It is found that the technique of quantitative determination of loratadine by differential spectrophotometry is accurate, correct, reproducible and linear, to determine its suitability for use in pharmaceutical analysis.
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1. Introduction 
Loratadine - H1-antihistamines second generation anti-
histamine non sedative effective long-term action to 
rapid and severe allergic effect. It does not affect the 
central nervous system, does not exhibit anticholiner-
gic and sedative action does not cause addiction. Also 
detects and anti vasoconstrictive effect on the nasal 
mucosa, prevents spasm of the bronchi, has a mem-
brane stabilizing effect and so on. Its use to quickly 
achieve remission and relapse prevention spending aller-
gic diseases, especially in children1 and in treatment of 
complex allergic disease, such as asthma and allergic 
rhinitis, allergic conjunctivitis, atopic dermatitis, etc2. 
Pharmaceutical market in Ukraine has many mono-drugs 
and some combination drugs that contain loratadine3.
The problem of the development of new methods for 
the quantitative determination of active pharmaceuti-
cal ingredients in the finished product was and remains 
relevant and at present there. Due to the large quantities 
of organic solvents for the test, complexity and sustain-
ability sample preparation and methods in general, the 
high cost of reagents and instruments - will increase the 
costs for analyzing both the laboratory quality control of 
medicines and in the Central Laboratory of pharmaceuti-
cal companies. Therefore, the development of new, more 
advanced and simple in execution methods of analysis of 
drugs remains a topical issue of modern pharmacy.
As we know from literature sources4, the substance is 
loratadine sufficiently studied in terms of pharmaceutical 
analysis: for its developed methods of identification and 
quantitative determination. Quantitative determination 
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of loratadine in medicines and methods of differential 
spectrophotometry and photo-colorimetry literature 
practically are not described. Therefore, the above 
mentioned methods we have chosen to quantify 
loratadine tablets.
1.1 The Purpose of the Work
Development and validation of quantitative determi-




The study was conducted on five samples loratadine 
tablets domestic producers «Zdorovja» (series 31012), 
«Lekchim» (series 100512), «Farmak» (series 330912), 
«Arterium» (series 40612), «Darnitsa» (series 200712). 
In this series using analytical equipment: UV Carry 
-spectrophotometer 50, electronic scales AVT-120-5DM; 
measuring vessel class, appropriate reagents that meet 
the requirements of SPU and pharmacopoeia standard 
sample (CRS) loratadine (certificate number 11 / 1-243 
of 02.12.13), acquired in the State enterprise «Ukrainian 
scientific center pharmacopoeia quality medicines».
2.2 Sample Preparation
Preliminary tests we have developed methods of identi-
fication of loratadine in tablets, one of which was based 
on qualitative reactions - the formation of hydroxamic 
acids5,6. Loratadine as the ester can form hydroxamic acid 
by reaction equation:
RCOOC2H5 + NH2OH → RCONHOH + C2H5OH
Hydroxamic acid ions Fe3 + forms a complex com-
pound of blue-red color, whose intensity can be measured 
spectrophotometrically:
3RCONHOH + FeCl3 → (RCONHO)3Fe + 3HCl.
Spectrophotometric method of quantitative 
determination of loratadine tablets by differential 
spectrophotometry below:
2.2.1 Test Solution 
The exact weight powdered tablets equivalent to 0.00104 
millimole loratadine is dissolved in methanol R and filtered 
into volumetric flask, add 0.5 ml of 2 mole hydroxylamine 
hydrochloride R in methanol R, 0.5 ml solution of 0.09 
millimole potassium hydroxide R in alcohol R, heated and 
cooled with shaking. The resulting solution is acidified 
with 6 drops of 2 mole hydrochloric acid R, add 0.2 ml 
of 0.26 millimole iron (III) chloride R1 diluted 10 times; 
appears bluish-red color. The resulting solution is adjusted 
methanol R to the mark and immediately measure the 
optical density.
2.2.2 Reference Solution
0.00104 millimole loratadine CRS dissolved in methanol 
R in a volumetric flask, add 0.5 ml of 2 mole hydroxyl-
amine hydrochloride R in methanol R, 0.5 ml solution 
of 0.09 millimole potassium hydroxide R in alcohol R is 
heated and cooled with shaking. The resulting solution is 
acidified with 6 drops of 2 mole hydrochloric acid R, add 
0.2 ml of 0.26 millimole iron (III) chloride R1 diluted 10 
times; appears bluish-red color. The resulting solution is 
adjusted methanol to the mark and immediately measure 
the optical density.
2.2.3 Compensation Solution
0.00104 millimole loratadine CRS dissolved in methanol R 
in a volumetric flask, add 0.5 ml solution of 0.09 millimole 
potassium hydroxide R in alcohol R, heated and cooled with 
shaking. The resulting solution is acidified with 6 drops 
of 2 mole hydrochloric acid R. The resulting solution is 
adjusted methanol to the mark and immediately measure 
the optical density. Absorbance of the test solution and 
reference solution is measured at 530 nm wavelength 
regarding compensation solution. Calculate the content 
of loratadine in a single tablet, in g, based on the average 
tablet weight, based on the declared loratadine content of 
CRS loratadine. Content loratadine tablets, g, calculated 
by formula (3.1).
Validation methods performed in accordance with 
the requirements of HFCs under the standard procedure 
of validation techniques quantification of medicines [7].
3. Results
During the procedure considered the following param-
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Table 1. The study of the stability analytical solution for the quantitative 
determination by photo-colorimetry of loratadine in tablets
№ Term stability studies, t, min Average RSDt, % Δt, % max δ, %
2,5 5 10 15 30
Ast 0,4840 0,4817 0,4753 0,4613 0,4437 0,4678 3,416 7,28 1,52
Ax 0,4787 0,4712 0,4660 0,4557 0,4393 0,4641 3,336 7,11
Table 2. The study of the stability analytical solution for the quantitative determination by 
spectrophotometry of loratadine in tablets
№ Term stability studies, t, min Average RSDt, 
%
max δ, %
0 15 30 45 60
Ast 0,4117 0,4117 0,4130 0,4130 0,4140 0,4123 0,311 1,52
Ax 0,4060 0,4053 0,4087 0,4053 0,4053 0,4057 0,299
Table 3. Statistical indicators metrological characteristics of methods





Gotten result, Z, % 101,17 99,63
relative standard deviation, Szі, % 4,53 0,83
The relative confidence interval, Δz, % 8,20 1,46
Critical for convergence results,Δas, % 4,80 4,80
Systematic error, δ 1,07 -0,37
Criterion uncertainty bias 1,52 1,52
Linearity




Free Member linear relationship, a -17,3389 2,5450
The critical value for free member, а 5,1200 5,1200
Sa 6,3161 1,3228
The correlation coefficient methods, r 0,9950 0,9997
Criterion linear correlation coefficient, 
Rc
0,9914 0,9914
Conclusion: does not comply Comply or correct 
Table 4. Effect of pH on the absorption of optical density analytical solutions





100 g / l potassium 
hydroxide R
1 0,315 0,220 0,325 0,0049 0,484 1,40 1,52
2 0,375 0,270 0,388 0,0047 0,467 1,36
3 0,450 0,320 0,460 0,0045 0,451 1,32
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robasnist, convergence, internal laboratory accuracy (pre-
cision), accuracy, reproducibility.
4. Discussion
To assess the model error of sample preparation solutions 
and standard working solution were calculated theoretical 
values  of uncertainty of analytical operations. Complete 
uncertainty for sample preparation photo-colorimetric 
and spectrophotometric methods are: Δsp = 1,02%, Δsp 
= 1,30% respectively. If validation photometric method of 
assay validation are first considered parameters such as 
stability analytical solution at the time, linearity, accuracy 
and convergence. The research methodology was carried 
out under the same conditions: in one day, in one device, 
by the same analyst. Check the stability of solutions was 
conducted for 30 minutes to 60 minutes and photo-col-
orimetric spectrophotometric method for analyzing the 
working standard solution and sample solutions. These 
tables indicate that the analytical solution is only stable 
for about 5 minutes, causing difficulties in conducting the 
experiment, so all the results obtained by this method for 
the first five minutes of cooking. Instability of analytical 
solutions can lead to deviations from the Beer-Lambert 
law and getting incorrect results. In this case, the stabil-






















































The relative standard deviation, Sri, % 1,1199
The relative confidence interval,Δz, % 0,1315
Systematic error,δ -0,185
Criterion uncertainty bias and error 1,52
ity of the solution is influenced by such factors: the rate 
of flow of a colorimetric reaction; conditions in which 
we determine the extent of coverage and working rooms; 
pH, concentration of loratadine and reagents; Properties 
hydroxamate iron; change the degree of dissociation of 
the compound in solution dilution. So to avoid errors 
when using this technique has important way to prepare 
analytical solutions.
Analytical solution spectrophotometric method stable 
for hours, which is enough to determine the absorbance. 
To confirm the specificity of the technique relied 
systematic error, which made solvent and reagents, that 
contribution placebo. For each method measured the 
optical density of the solutions placebo and working 
standards. The values  of optical densities placebo solution 
number 1 and standard methods for photo-colorimetric: 
Ablank = 0.001; Ast = 0,389, hence δexc = 100 • 0,001 / 
0,389 = 0,26%. Effect placebo solution number 2 results 
spectrophotometric method is: Ablank = 0.001; Ast = 0,468, 
δexc = 0,21%, confirming the absence of a meaningful 
impact on the measurement results for both techniques. 
To assess the linearity and accuracy were obtained 15 
values  of optical densities of model solutions and 4 of 
the optical densities for solution standard. The results 
are presented in the table. Calculated ratio of average 
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values  of optical densities for each of the 15 solutions 
to the mean absorbance reference solution to give value 
= Si Hui / Sst • 100%, Yi = (Ai / Ast) • 100. Worked in 
normalized coordinates, giving the concentration and 
analytical signal as a percentage of the nominal value. 
They found as the value of Z = 100 • (Yi / Xi), which is 
found concentrations as a percentage of the administered.
The results indicate that the method photo-colorimet-
ric do not meet modern criteria for analytical methods for 
quantitative determination of parameters such as stabil-
ity, accuracy and linearity, so other validation parameters 
(robasnist, convergence and inter-laboratory precision) 
determined only spectrophotometric methods.
Robustness evaluation was performed taking into 
account the type of methodology, in this case spectropho-
tometric method for studying the following parameters: 
stability over time analytic solutions prepared by the 
method (described above); effect of pH on the stability 
of the optical absorption solution ethacridine. The results 
of studying the stability of analytical solutions spectro-
photometric method for hours in the table below and 
demonstrate the stability of analytical solutions, inequal-
ity Δt% ≤0,32 • maxΔAs = maxδ performed. To study 
the effect of pH for the test solution (85%, 100%, 115%) 
was added to 1-2 drops of HCl or KOH solution to play 
fluctuation pH of ± 10%. For model solutions obtained 
measured optical density at the selected wavelength. 
Internal laboratory accuracy (precision) was assessed by 
the analysis of 15 samples of various model series, which 
was carried out in two different days and different analysts 
in one laboratory conditions. To prepare two different 
series were taken in our various sample concentration 
range. To prepare dilutions of these series use different 
measuring laboratory dishes. During the preparation of 
solutions and of technique was possible fluctuations in 
temperature, humidity, atmospheric pressure and other 
factors influencing the internal laboratory analysis. The 
technique is correct, because ΔZ, calculated by the ratio, 
the requirements: ΔZ% ≤ maxΔAs = 4,8%. The method 
has significant bias. To examine the reproducibility of this 
method in terms of other laboratories, we measured the 
optical density of the solutions of a series of model solu-
tions loratadine on different hardware, different days in 
three different laboratories. The results are presented in 
the table and are the results of comparing statistical devia-
tions of three different experiments, associations and the 
average value of a single relative standard deviation. The 
resulting metrological data show that this technique can 
be replicated in other laboratories with confidence prob-
ability 95% deviation of the unit value of 100 ± 1,23%. The 
results of analysis show that this technique can be used to 
quantify the loratadine tablets and can be included in the 
quality control methods for loratadine in tablets.
5. Conclusion
In conclusion, we developed spectrophotometric and 
photo-colorimetric methods of quantitative determina-
tion of loratadine in tablets. These methods are showed 
good following parameters: specificity, linearity, range, 
accuracy (convergence) and accuracy, robasnist, the 
results of which revealed that spectrophotometric method 
can be used for the determination of loratadine in tablets 
and can be used for quality control of tablets.
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